Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
May 22, 2023 (filed on May 24, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,750,000Price:$0.02
-
Jan 23, 2023 (filed on Jan 31, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:2,000,000Price:$0.02
-
Dec 30, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,850,000Price:$0.02
-
Dec 21, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:100,000Price:$0.03
-
Dec 18, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:J - Other transaction# or value acquired/disposed of:-216,666Price:--
-
Dec 16, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:65,000Price:$0.03
-
Dec 15, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:78,400Price:$0.03
-
Dec 14, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:94,089Price:$0.02
-
Dec 13, 2022 (filed on Dec 14, 2022)Insider Name:Young Lachlan GrantOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,000,000Price:--
-
Dec 13, 2022 (filed on Dec 14, 2022)Insider Name:Young Lachlan GrantOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:J - Other transaction# or value acquired/disposed of:-6,000,000Price:--
Filings by filing date
-
May 22, 2023 (filed on May 24, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,750,000Price:$0.02
-
Jan 23, 2023 (filed on Jan 31, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:2,000,000Price:$0.02
-
Dec 18, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:J - Other transaction# or value acquired/disposed of:-216,666Price:--
-
Dec 30, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,850,000Price:$0.02
-
Dec 21, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:100,000Price:$0.03
-
Dec 16, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:65,000Price:$0.03
-
Dec 15, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:78,400Price:$0.03
-
Dec 14, 2022 (filed on Jan 04, 2023)Insider Name:Smith Clarence EdwardOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:94,089Price:$0.02
-
Dec 13, 2022 (filed on Dec 14, 2022)Insider Name:Young Lachlan GrantOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,000,000Price:--
-
Dec 13, 2022 (filed on Dec 14, 2022)Insider Name:Young Lachlan GrantOwnership Type:Direct OwnershipSecurities:WarrantNature of Transaction:J - Other transaction# or value acquired/disposed of:-6,000,000Price:--
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 109 W. MAIN ST. DALTON OH 44618 |
Tel: | N/A |
Website: | https://www.protokinetix.com |
IR: | See website |
Key People | ||
Clarence E. Smith Chairman of the Board, President, Chief Executive Officer | Michael Richard Guzzetta Chief Financial Officer |
Business Overview |
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company's anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. The Company has not developed a commercially viable product and has not generated any revenue. |
Financial Overview |
For the three months ended 31 March 2023, ProtoKinetix, Inc. revenues was not reported. Net loss decreased 79% to $107K. Lower net loss reflects Share-based compensation decrease from $242K (expense) to $0K, Research and development decrease of 86% to $23K (expense), General and administrative decrease of 44% to $33K (expense). |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $8.38M as of Mar 31, 2023 |
Annual revenue (TTM): | $0.00M as of Mar 31, 2023 |
EBITDA (TTM): | -$1.43M as of Mar 31, 2023 |
Net annual income (TTM): | -$1.50M as of Mar 31, 2023 |
Free cash flow (TTM): | -$0.69M as of Mar 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 327,880,151 as of Apr 24, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |